Finance

Skin in the Game for Dermata Therapeutics, Inc. (NASDAQ:DRMA) Big Gains on Positive Topline Results from Cosmetic Study

Nasdaq reports network disruption, US equities data feeds impacted

Global tech sell-off deepens as enthusiasm for AI stocks wobbles

Berkshire Hathaway Outperformed the S&P 500 Over a 60-Year Period Under Warren Buffett. Here's the Stock That Could Help Continue the Streak Under Greg Abel.